Literature DB >> 8085587

Decrease in normal human corneal sensitivity with topical diclofenac sodium.

K Szerenyi1, K Sorken, J J Garbus, M Lee, P J McDonnell.   

Abstract

We tested the effect of topical diclofenac sodium on corneal sensitivity in the human eye. Corneal sensitivity was measured in ten adult subjects with the Cochet-Bonnet esthesiometer before, and immediately after, applying one drop of diclofenac sodium 0.1% in one eye and one drop of diclofenac vehicle in the other eye. Application was repeated every five minutes for 20 minutes; then no more drops were applied, and corneal sensitivity was measured every 15 minutes until sensitivity measurements returned to baseline levels. Diclofenac sodium decreased corneal sensitivity significantly (P = .0001) in all ten subjects, compared with eyes treated with the vehicle. The effect of diclofenac sodium increased as additional drops were administered. After the drug instillation was stopped, corneal sensitivity returned to baseline measurements within less than an hour in all the subjects. Diclofenac sodium substantially lowers sensitivity in normal, unoperated-on human corneas; the vehicle has no measurable effect on sensitivity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8085587     DOI: 10.1016/s0002-9394(14)72954-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Analgesic effect of topical sodium diclofenac 0.1% drops during retinal laser photocoagulation.

Authors:  D Weinberger; Y Ron; H Lichter; I Rosenblat; R Axer-Siegel; Y Yassur
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

Review 2.  The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology.

Authors:  P Koay
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

Review 3.  Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.

Authors:  Bruce I Gaynes; Richard Fiscella
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis.

Authors:  Gennaro D'Angelo; Alessandro Lambiase; Magdalena Cortes; Roberto Sgrulletta; Roberta Pasqualetti; Ambra Lamagna; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-15       Impact factor: 3.117

5.  Topical analgesia for superficial corneal injuries.

Authors:  A K Brahma; S Shah; V F Hillier; D McLeod; T Sabala; A Brown; J Marsden
Journal:  J Accid Emerg Med       Date:  1996-05

Review 6.  The role of NSAIDs in the management of postoperative ophthalmic inflammation.

Authors:  Joseph Colin
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Corneal sensitivity after topical bromfenac sodium eye-drop instillation.

Authors:  Kaori Yanai; Jane Huang; Kazuaki Kadonosono; Eiichi Uchio
Journal:  Clin Ophthalmol       Date:  2013-04-17

8.  Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK.

Authors:  Xiao Jing Wang; Sze H Wong; Roshan Givergis; Emil W Chynn
Journal:  Clin Ophthalmol       Date:  2011-10-07

Review 9.  Congenital Corneal Anesthesia and Neurotrophic Keratitis: Diagnosis and Management.

Authors:  Flavio Mantelli; Chiara Nardella; Eloisa Tiberi; Marta Sacchetti; Alice Bruscolini; Alessandro Lambiase
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

10.  Effects of topical flurbiprofen sodium, diclofenac sodium, ketorolac tromethamine and benzalkonium chloride on corneal sensitivity in normal dogs.

Authors:  Raquel de Araújo Cantarella; Juliana Kravetz de Oliveira; Daniel M Dorbandt; Fabiano Montiani-Ferreira
Journal:  Open Vet J       Date:  2017-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.